'Filling in the missing pieces': How AI is transforming drug discovery, development and innovation

Brendan Frey's passion for genomics -- the science of analyzing and interpreting our DNA -- was ignited in 2002. When a family member was diagnosed with a genetic disorder, there wasn't enough information for doctors to evaluate the full scope of the problem, let alone fix it. "I thought we should live in a better world," Frey says. "One in which we can accurately detect and treat genetic diseases." A decade ago, the odds of that happening anytime in the foreseeable future were decidedly small.